Survival and postoperative complication in daily practice after neoadjuvant therapy in resectable stage IIIA-N2 non-small cell lung cancer

Interactive Cardiovascular and Thoracic Surgery

Volumn 2, Issue 4, 2003, Pages 558-562

  Barlési, Fabrice ^a   Doddoli, Christophe ^a   Chetaille, Bruno ^a   Torre, Jean Philippe ^b   Giudicelli, Roger ^a   Thomas, Pascal ^a   Kleisbauer, Jean Pierre ^a   Fuentes, Pierre ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

N2; Neoadjuvant chemotherapy; Non small cell lung cancer; Pathological response; Postoperative complication; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; MITOMYCIN; NAVELBINE; PACLITAXEL;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DATA ANALYSIS; DEMOGRAPHY; FEMALE; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORTALITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME;

EID: 1642498145     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9293(03)00138-5     Document Type: Review

References (17)

1. Rosell R., Gomez-Codina J., Camps C., Maestre J., Padille J., Canto A., Mate J.L., Li S., Roig J., Olazabal A., Canela M., Ariza A., Skacel Z., Morera-Prat J., Abad A. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 330:1994;153-158.
2. Roth J.A., Fossella F., Komaki R., Ryan M.B., Putnam J.B. Jr., Lee J.S., Dhingra H., De Caro L., Chasen M., McGavran M. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst. 86:1994;673-680.
3. Pass H.I., Pogrebniak H.W., Steinberg S.M., Mulshine J., Minna J. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg. 53:1992;992-998.
4. Yoneda S., Hibino S., Gotoh I., Sakai H., Noguchi Y., Yamamoto M. A comparative trial on induction chemotherapy followed by surgery (CRS) or immediate surgery (IS) for stage III NSCLC. Proc Am Soc Clin. 14:1995;A1128.
5. Depierre A., Milleron B., Moro-Sibilot D., Chevret S., Quoix E., Lebeau B., Braun D., Breton J.L., Lemarie E., Gouva S., Paillot N., Brechot J.M., Janicot H., Lebas F.X., Terrioux P., Clavier J., Foucher P., Monchatre M., Coetmeur D., Level M.C., Leclerc P., Blanchon F., Rodier J.M., Thiberville L., Villeneuve A., Westeel V., Chastang C., French Thoracic Cooperative Group. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol. 20:2002;247-253.
6. Perry M.C., Deslauriers J., Albain K.S., Choi N.C., Depierre A., Johnston M.R., Lacquet L.K., Payne D.G., Putnam J.B., Sculier J.P., Shepherd F.A. Induction treatment for resectable non-small cell lung cancer. Lung Cancer. 17:1997;S15-S18.
7. Eberhardt W., Hepp R., Korfee S., Stamatis G. Current status of adjuvant and neoadjuvant chemotherapy in resectable nonsmall cell lung cancer. Eur Respir Rev. 84:2002;196-207.
8. Martin J., Ginsberg R.J., Venkatraman E.S., Bains M.S., Downey R.J., Korst R.J., Kris M.G., Rusch V.W. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. J Clin Oncol. 20:2002;1989-1995.
9. Choi N.C., Carey R.W., Daly W., Mathisen D., Wain J., Wright C., Lynch T., Grossbard M., Grillo H. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol. 15:1997;712-722.
10. Bueno R., Richards W.G., Swanson S.J., Jaklitsch M.T., Lukanich J.M., Mentzer S.J., Sugarbaker D.J. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg. 70:2000;1826-1831.
11. Van Schil P., van der Schoot J., Poniewierski J., Pauwels M., Carp L., Germonpre P., De Backer W. Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer. Lung Cancer. 37:2002;281-285.
12. Pieterman R.M., Van Putten J.W., Meuzelaar J.J., Mooyaart E.L., Vaalburg W., Koeter G.H., Fidler V., Pruim J., Groen H.J. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med. 343:2000;254-261.
13. Hoekstra C.J., Hoekstra O.S., Stroobants S.G., Vansteenkiste J., Nuyts J., Smit E.F., Boers M., Twisk J.W., Lammertsma A.A. Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET. J Nucl Med. 43:2002;1304-1309.
14. Johnstone D.W., Byhardt R.W., Ettinger D., Scott C.B. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 54:2002;365-369.
15. Choi Y.S., Shim Y.M., Kim J., Kim K. Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer. Eur J Cardiothorac Surg. 22:2002;695-700.
16. Miller A.B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 47:1981;207-214.
17. Mountain C.F. Revisions in the International system for staging lung cancer. Chest. 111:1997;1710-1717.